[FG] Granziera Cristina

Cagol, A. and Granziera, C. (2026) ‘Turning Our Gaze to the Anterior Visual Pathway’, Neurology, 106(4). Available at: https://doi.org/10.1212/wnl.0000000000214590.

Pretzsch, Roxanne et al. (2026) ‘Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)—A meta-regression of randomized controlled trials’, Multiple Sclerosis Journal [Preprint]. Available at: https://doi.org/10.1177/13524585251407973.

Cagol, A. et al. (2026) ‘Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis’, Advanced Science [Preprint]. Available at: https://doi.org/10.1002/advs.202512946.

Galbusera, Riccardo (2026) Unraveling the Heterogeneity of Multiple Sclerosis Pathology in the Brain through Quantitative MRI. Doctoral Thesis. University of Basel.

Gkotsoulias, Dimitrios G. et al. (2025) ‘Bridging mesoscopic and microscopic scales in multiple sclerosis: Post mortem brain block multi-contrast 9.4T MRI and histology quantification’, STAR Protocols. 17.11.2025, 6(4). Available at: https://doi.org/10.1016/j.xpro.2025.104203.

Fabi, Adriano et al. (2025) ‘Neurolymphatic clearance in neurodegenerative disease: emerging mechanisms and potential translational strategies’, JPRAS Open [Preprint]. 17.12.2025. Available at: https://doi.org/10.1016/j.jpra.2025.12.013.

Yu, Hyunjae et al. (2025) ‘Multi-center evaluation of Neurophet AQUA for brain MRI segmentation: T1 compared with FreeSurfer and T2-FLAIR compared with ground truth’, Frontiers in Neurology, 16. Available at: https://doi.org/10.3389/fneur.2025.1672133.

Cagol, A. et al. (2025) ‘The effect of disease-modifying therapies on brain volume loss and disability accumulation in multiple sclerosis: a systematic review and network meta-analysis’, 59. Available at: https://doi.org/10.1016/j.lanepe.2025.101476.

Li, Hao et al. (2025) ‘Spatial and temporal effects of cortical cerebral microinfarcts on the cortical and subcortical regions in cerebral small vessel disease’, Alzheimer S and Dementia, 21. Available at: https://doi.org/10.1002/alz.71056.

Maceski, Aleksandra Maleska et al. (2025) ‘GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis’, Brain [Preprint]. Available at: https://doi.org/10.1093/brain/awaf433.

Sachdev, Perminder S. et al. (2025) ‘Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia-The VasCog-2-WSO Criteria’, JAMA Neurology, 82, pp. 1103–1112. Available at: https://doi.org/10.1001/jamaneurol.2025.3242.

Cai, M. et al. (2025) ‘Cholinergic Disruption Contributes to Motoric Cognitive Dysfunction in Cerebral Small Vessel Disease’, Stroke [Preprint]. Available at: https://doi.org/10.1161/strokeaha.125.052256.

David R, van Nederpelt et al. (2025) ‘User requirements for quantitative radiological reports in multiple sclerosis’, European Radiology, 35. Available at: https://doi.org/10.1007/s00330-025-11544-x.

Cortese, Rosa et al. (2025) ‘Deep Learning Modeling to Differentiate Multiple Sclerosis from MOG Antibody-Associated Disease’, Neurology, 105. Available at: https://doi.org/10.1212/wnl.0000000000214075.

Chen, Xinjie et al. (2025) ‘Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis’, Neurology Neuroimmunology & Neuroinflammation, 12(5). Available at: https://doi.org/10.1212/nxi.0000000000200459.

Filler, Jule et al. (2025) ‘Risk factors for dementia and cognitive impairment within 5 years after stroke: a prospective multicentre cohort study’, Lancet Regional Health Europe, 56. Available at: https://doi.org/10.1016/j.lanepe.2025.101428.

Riccardo Galbusera et al. (2025) ‘Quantitative T1 is sensitive to cortical remyelination in multiple sclerosis: A postmortem MRI study’, Brain Pathology, 35, p. e70010. Available at: https://doi.org/10.1111/bpa.70010.

Cerfontaine, Minne N. et al. (2025) ‘Association Between Vascular NOTCH3 Aggregation and Disease Severity in a CADASIL Cohort – Implications for NOTCH3 Variant-Specific Disease Prediction’, Annals of Neurology, 98, pp. 273–285. Available at: https://doi.org/10.1002/ana.27240.

Einsiedler, Maximilian et al. (2025) ‘Treatment Strategies and Disease Activity During Pregnancy and Postpartum’, Neurology Clinical Practice, 15(4). Available at: https://doi.org/10.1212/cpj.0000000000200499.

Cagol, A. and Rovira, À. (2025) ‘Reinforcing the evidence framework for paramagnetic rim lesions in MS: Advancing toward broad clinical integration’, Multiple Sclerosis Journal, 31. Available at: https://doi.org/10.1177/13524585251349971.

Kan, C.N. et al. (2025) ‘Tract-specific white matter hyperintensities and neuropsychiatric syndromes: A multicentre memory clinic study’, Journal of Neurology, Neurosurgery and Psychiatry, 96(7), pp. 697–704. Available at: https://doi.org/10.1136/jnnp-2024-334264.

Kneihsl, Markus et al. (2025) ‘Topographic Localization of Chronic Cerebellar Ischemic Lesions: Implications for Underlying Cause’, Stroke, 56, pp. 1823–1831. Available at: https://doi.org/10.1161/STROKEAHA.124.049337.

Müller, Jannis et al. (2025) ‘Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis’, JAMA Neurology. 14.04.2025, 82(6), pp. 614–625. Available at: https://doi.org/10.1001/jamaneurol.2025.0495.

Cagol, A. and Granziera, C. (2025) ‘Rethinking Multiple Sclerosis Diagnosis’, Neurology Open Access, 1(2). Available at: https://doi.org/10.1212/wn9.0000000000000021.

Neuhaus, D. et al. (2025) ‘Exploring Potential Biomarkers for Amyotrophic Lateral Sclerosis Using Postmortem In Situ Magnetic Resonance Imaging’, NMR in Biomedicine, 38(6). Available at: https://doi.org/10.1002/nbm.70059.

Damiano, Marastoni et al. (2025) ‘Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis’, Neurology: Neuroimmunology and NeuroInflammation, 12(4), p. e200399. Available at: https://doi.org/10.1212/nxi.0000000000200399.

Denecke, Jannis et al. (2025) ‘Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease’, Alzheimer S and Dementia, 21. Available at: https://doi.org/10.1002/alz.70127.

Géraldine, Androdias et al. (2025) ‘De-escalating and discontinuing disease-modifying therapies in multiple sclerosis’, Brain, 148(5), pp. 1459–1478. Available at: https://doi.org/10.1093/brain/awae409.

Greselin, Martina et al. (2025) ‘AI-assisted identification of disability patterns within identical EDSS grades’, Multiple Sclerosis Journal, 31(6), pp. 677–688. Available at: https://doi.org/10.1177/13524585251327300.

Martina, Greselin et al. (2025) ‘AI-assisted identification of disability patterns within identical EDSS grades’, Multiple Sclerosis Journal, 31(6), pp. 677–688. Available at: https://doi.org/10.1177/13524585251327300.

Kaminska, Karolina et al. (2025) ‘Bi-allelic variants in three genes encoding distinct subunits of the vesicular AP-5 complex cause hereditary macular dystrophy’, American Journal of Human Genetics, 112(4), pp. 808–828. Available at: https://doi.org/10.1016/j.ajhg.2025.02.015.

Bédard, S. et al. (2025) ‘Towards contrast-agnostic soft segmentation of the spinal cord’, Medical Image Analysis, 101, p. 103473. Available at: https://doi.org/10.1016/j.media.2025.103473.

Müller, Jannis et al. (2025) ‘Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study’, CNS Drugs, 39(4), pp. 403–416. Available at: https://doi.org/10.1007/s40263-025-01164-w.

Lukasz Kolakowski, Katarina Alexandra Ebner and Athina Papadopoulou (2025) ‘Headache and Facial Pain in Multiple Sclerosis: A Narrative Review’, Clinical and translational neuroscience [Preprint]. Available at: https://doi.org/10.3390/ctn9010016.

Stringer, Michael S. et al. (2025) ‘Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease’, Annals of Neurology, 97(3), pp. 483–498. Available at: https://doi.org/10.1002/ana.27136.

Elisabeth A, Kappos et al. (2025) ‘The LYMPH trial: comparing microsurgical with conservative treatment for chronic breast cancer-associated lymphoedema - study protocol of a pragmatic randomised international multicentre superiority trial’, BMJ Open, 15(2), p. e090662. Available at: https://doi.org/10.1136/bmjopen-2024-090662.

Benno Gesierich et al. (2025) ‘Extended Technical and Clinical Validation of Deep Learning-Based Brainstem Segmentation for Application in Neurodegenerative Diseases’, Human Brain Mapping, 46(3), p. e70141. Available at: https://doi.org/10.1002/hbm.70141.

Gesierich, Benno et al. (2025) ‘Extended Technical and Clinical Validation of Deep Learning-Based Brainstem Segmentation for Application in Neurodegenerative Diseases’, Human Brain Mapping, 46. Available at: https://doi.org/10.1002/hbm.70141.

Gordaliza, Pedro M. et al. (2025) ‘Fluid and White Matter Suppression Contrasts MRI Improves Deep Learning Detection of Multiple Sclerosis Cortical Lesions’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2025.01.19.25320792.

Gravesteijn, Gido et al. (2025) ‘Disease Severity Staging System for NOTCH3 -Associated Small Vessel Disease, Including CADASIL’, JAMA Neurology, 82(1), pp. 49–60. Available at: https://doi.org/10.1001/jamaneurol.2024.4487.

Benkert, Pascal et al. (2025) ‘Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis’, Annals of Neurology. 16.10.2024, 97(1), pp. 104–115. Available at: https://doi.org/10.1002/ana.27096.

Durrer, Alicia (2025) Leveraging Denoising Diffusion Probabilistic Models for Brain Magnetic Resonance Image Processing and Analysis. Doctoral Thesis. University of Basel.

Durrer, Alicia et al. (2025) ‘Denoising Diffusion Models for 3D Healthy Brain Tissue Inpainting’, in Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) . Marrakesh, Morocco: Springer Science and Business Media Deutschland GmbH (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) ), pp. 87–97. Available at: https://doi.org/10.1007/978-3-031-72744-3_9.

Frey Nascimento, Antje et al. (2025) ‘Talking placebo: a qualitative study of patients’ attitudes toward open-label placebo implementation into clinical practice’, Frontiers in Psychology, 16. Available at: https://doi.org/10.3389/fpsyg.2025.1533663.

Gesierich, Benno et al. (2025) ‘Technical and clinical validation of a novel deep learning-based white matter hyperintensity segmentation tool’, Cerebral Circulation Cognition and Behavior, 9. Available at: https://doi.org/10.1016/j.cccb.2025.100393.

Gordaliza, Pedro M. et al. (2025) ‘Fluid and White Matter Suppression contrasts MRI improves Deep Learning detection of Multiple Sclerosis Cortical Lesions’, Neuroimage Clinical, 48. Available at: https://doi.org/10.1016/j.nicl.2025.103818.

Molchanova, Nataliia et al. (2025) ‘Structural-based uncertainty in deep learning across anatomical scales: Analysis in white matter lesion segmentation’, Computers in Biology and Medicine, 184. Available at: https://doi.org/10.1016/j.compbiomed.2024.109336.

Müller, Jannis, Derfuss, Tobias and Yaldizli, Özgür (2025) ‘Klinische Grundlagen der MS’, in Multiple Sklerose verstehen und behandeln. Springer (Multiple Sklerose verstehen und behandeln).

Pham, Stanley DT et al. (2025) ‘Small vessel dysfunction at 7T MRI locally predicts white matter damage progression in CADASIL’, Journal of Cerebral Blood Flow and Metabolism [Preprint]. Available at: https://doi.org/10.1177/0271678X251369257.

Sharmin, Sifat et al. (2025) ‘MSoutcomes: CORe Multiple Sclerosis Outcomes Toolkit’. Available at: https://doi.org/https://CRAN.R-project.org/package=MSoutcomes.

Spagnolo, Federico (2025) Toward clinical translation: advancing the understanding of AI models in multiple sclerosis. Doctoral Thesis. University of Basel.

Spagnolo, F. et al. (2025) ‘Exploiting XAI Maps to Improve MS Lesion Segmentation and Detection in MRI’, in Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) . Cham: Springer Science and Business Media Deutschland GmbH (Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) ), pp. 121–131. Available at: https://doi.org/10.1007/978-3-031-77610-6_12.

Vlegels, Naomi et al. (2025) ‘The relation between cerebral small vessel function and white matter microstructure in monogenic and sporadic small vessel disease - the ZOOM@SVDs study’, Cerebral Circulation Cognition and Behavior, 8. Available at: https://doi.org/10.1016/j.cccb.2025.100383.

Voorter, Paulien H.M. et al. (2025) ‘Heterogeneity and Penumbra of White Matter Hyperintensities in Small Vessel Diseases Determined by Quantitative MRI’, Stroke, 56(1), pp. 128–137. Available at: https://doi.org/10.1161/strokeaha.124.047910.

Barakovic, Muhamed et al. (2024) ‘A novel imaging marker of cortical “cellularity” in multiple sclerosis patients’, Scientific Reports, 14(1). Available at: https://doi.org/10.1038/s41598-024-60497-6.

Weigel, M. et al. (2024) ‘Feasibility of interleaved multislice averaged magnetization inversion-recovery acquisitions of the spinal cord’, Magnetic Resonance in Medicine, 92(6), pp. 2588–2595. Available at: https://doi.org/10.1002/mrm.30223.

Scalfari, Antonio et al. (2024) ‘Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions’, Annals of Neurology, 96(5), pp. 826–845. Available at: https://doi.org/10.1002/ana.27034.

Gordaliza, P.M. et al. (2024) ‘Towards Longitudinal Characterization of Multiple Sclerosis Atrophy Employing SynthSeg Framework and Normative Modeling’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.09.17.613272.

Cagol, Alessandro et al. (2024) ‘Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis’, Neurology: Neuroimmunology and NeuroInflammation, 11(6). Available at: https://doi.org/10.1212/nxi.0000000000200299.

Rocca, Maria A. et al. (2024) ‘Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis’, The Lancet Regional Health - Europe, 44. Available at: https://doi.org/10.1016/j.lanepe.2024.100978.

Wendebourg, Maria Janina et al. (2024) ‘The Lateral Corticospinal Tract Sign: An MRI Marker for Amyotrophic Lateral Sclerosis’, Radiology, 312(3). Available at: https://doi.org/10.1148/radiol.231630.

Müller, Jannis et al. (2024) ‘Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions’, Neurology. 30.08.2024, 103(6). Available at: https://doi.org/10.1212/wnl.0000000000209604.

Spagnolo, F. et al. (2024) ‘Exploiting XAI maps to improve MS lesion segmentation and detection in MRI’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.08.29.610090.

Schoenholzer, Kean et al. (2024) ‘Hemimacular Thinning Due to Lesions in the Lateral Geniculate Nucleus in 2 Patients with Neuroinflammatory Diseases’, Neurology: Neuroimmunology and NeuroInflammation. 14.08.2024, 11(6). Available at: https://doi.org/10.1212/nxi.0000000000200297.

Sastre-Garriga, J. et al. (2024) ‘Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management’, Neurology, 103(3). Available at: https://doi.org/10.1212/wnl.0000000000209677.

Cagol, Alessandro, Tsagkas, Charidimos and Granziera, Cristina (2024) ‘Advanced Brain Imaging in Central Nervous System Demyelinating Diseases’, Neuroimaging Clinics of North America, 34(3), pp. 335–357. Available at: https://doi.org/10.1016/j.nic.2024.03.003.

Graber, M. et al. (2024) ‘Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy’, Clinical and Translational Neuroscience, 8(3), p. 26. Available at: https://doi.org/10.3390/ctn8030026.

Moura, João et al. (2024) ‘Emerging imaging markers in radiologically isolated syndrome: implications for earlier treatment initiation’, Neurological Sciences, 45(7), pp. 3061–3068. Available at: https://doi.org/10.1007/s10072-024-07402-1.

Schuchardt, F.F. et al. (2024) ‘Clinical value of neuroimaging indicators of intracranial hypertension in patients with cerebral venous thrombosis’, Neuroradiology, 66(7), pp. 1161–1176. Available at: https://doi.org/10.1007/s00234-024-03363-6.

Ciccarelli, O. et al. (2024) ‘Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis’, Neurology, 103(1). Available at: https://doi.org/10.1212/wnl.0000000000209444.

Ocampo-Pineda, Mario et al. (2024) ‘Patients with progression independent of relapse activity show increased white matter degeneration on diffusion tensor imaging maps’, Clinical and Translational Neuroscience. MDPI, 8(22).

Hirt, Julian et al. (2024) ‘Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis’, Journal of Neurology, 271(6), pp. 3131–3141. Available at: https://doi.org/10.1007/s00415-024-12366-5.

Wendebourg, Maria Janina et al. (2024) ‘Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis’, European Journal of Neurology, 31(6). Available at: https://doi.org/10.1111/ene.16268.

Wendebourg, Maria Janina et al. (2024) ‘Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis’, European Journal of Neurology, 31(6). Available at: https://doi.org/10.1111/ene.16268.

Müller, Jannis et al. (2024) ‘Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis’, Brain and Behavior. 30.04.2024, 14(5). Available at: https://doi.org/10.1002/brb3.3498.

Papadopoulou, Athina et al. (2024) ‘Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus’, Clinical Neurophysiology. 20.02.2024, 161, pp. 122–132. Available at: https://doi.org/10.1016/j.clinph.2024.02.020.

Weigel, M. et al. (2024) ‘Cerebellar Ex Vivo Magnetic Resonance Imaging at its Feasibility Limit: Up to 77-Microns Isotropic Resolution using Low-Bandwidth Balanced Steady State Free Precession (LoBa-bSSFP) Sequences and 3T Standard Equipment’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.04.18.589707.

Christensen, R.H. et al. (2024) ‘Differences in Cortical Morphology in People With and Without Migraine A Registry for Migraine (REFORM) MRI Study’, Neurology, 102(9). Available at: https://doi.org/10.1212/wnl.0000000000209305.

Hirt, Julian et al. (2024) ‘Use of pragmatic randomized trials in multiple sclerosis: A systematic overview’, Multiple Sclerosis Journal, 30(4-5), pp. 463–478. Available at: https://doi.org/10.1177/13524585231221938.

Wenger, Antonia, Calabrese, Pasquale and Granziera, Cristina (2024) ‘Unraveling the cerebellum’s role in multiple sclerosis’, Current Opinion in Behavioral Sciences, 56. Available at: https://doi.org/10.1016/j.cobeha.2024.101357.

Janiaud, Perrine et al. (2024) ‘MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial’, medRxiv (Cold Spring Harbor Laboratory) [Preprint]. Cold Spring Harbor Laboratory (medRxiv (Cold Spring Harbor Laboratory)). Available at: https://doi.org/10.1101/2024.03.22.24304720.

Callegari, Ilaria et al. (2024) ‘Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5’, Brain, 147(3), pp. 839–848. Available at: https://doi.org/10.1093/brain/awad424.

Federau, Christian et al. (2024) ‘Evaluation of the quality and the productivity of neuroradiological reading of multiple sclerosis follow-up MRI scans using an intelligent automation software’, Neuroradiology, 66(3), pp. 361–369. Available at: https://doi.org/10.1007/s00234-024-03293-3.

Vermersch, P. et al. (2024) ‘Inhibition of CD40L with Frexalimab in Multiple Sclerosis’, New England Journal of Medicine, 390(7), pp. 589–600. Available at: https://doi.org/10.1056/nejmoa2309439.

Oechtering, Johanna et al. (2024) ‘Complement Activation Is Associated With Disease Severity in Multiple Sclerosis’, Neurology: Neuroimmunology and NeuroInflammation, 11(2). Available at: https://doi.org/10.1212/nxi.0000000000200212.

Cagol, Alessandro et al. (2024) ‘Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis’, JAMA Neurology, 81(2), pp. 143–153. Available at: https://doi.org/10.1001/jamaneurol.2023.4737.

Cagol, Alessandro et al. (2024) ‘Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS’, Neurology, 102(1). Available at: https://doi.org/10.1212/wnl.0000000000207768.

Chen, Xinjie (2024) Advanced magnetic resonance imaging in multiple sclerosis: disentangling aging and pathology effects. Doctoral Thesis. Universität Basel .

Durrer, Alicia et al. (2024) ‘Denoising diffusion models for 3D healthy brain tissue inpainting’, in Medical Image Computing and Computer Assisted Interventions. Marrakesh (Medical Image Computing and Computer Assisted Interventions).

Einsiedler, Matthias et al. (2024) ‘Multiple sclerosis treatment strategies and disease activity during pregnancy and post-partum: real-world data from the Swiss MS cohort.’, Multiple Sclerosis Journal. Copenhagen: SAGE (ECTRIMS 2024), 1 January.

Granziera C (2024) ‘Towards Longitudinal Characterization of Multiple Sclerosis Atrophy Employing SynthSeg Framework and Normative Modeling’, bioRxiv [Preprint]. Available at: https://www.biorxiv.org/content/10.1101/2024.09.17.613272v1.

Harrison, Daniel M. et al. (2024) ‘The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative’, Brain Communications, 6(5). Available at: https://doi.org/10.1093/braincomms/fcae359.

Müller, Jannis et al. (2024) ‘Choroid Plexus Volume in Temporal Relation to Relapse Activity in Multiple Sclerosis’, in Multiple Sclerosis Journal. Copenhagen (40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis). Available at: https://doi.org/ https://doi.org/10.1177/13524585241269219.

Müller, Jannis et al. (2024) ‘A standardised definition of progression independent of relapse activity in multiple sclerosis’, Multiple Sclerosis Journal. Copenhagen: SAGE (ECTRIMS 2024), 1 January.

Spagnolo, Federico et al. (2024) ‘Down-sampling in diffusion MRI: a bundle-specific DTI and NODDI study’, Frontiers in Neuroimaging, 3. Available at: https://doi.org/10.3389/fnimg.2024.1359589.

Galbusera, Riccardo et al. (2023) ‘Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis’, Neurology, 102(3), p. e207966. Available at: https://doi.org/10.1212/wnl.0000000000207966.

Galbusera, Riccardo et al. (2023) ‘Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis’, Neurology, 102(3). Available at: https://doi.org/10.1212/wnl.0000000000207966.

Abdelhak, Ahmed et al. (2023) ‘Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis’, JAMA Neurology, 80(12), pp. 1317–1325. Available at: https://doi.org/10.1001/jamaneurol.2023.3997.

Müller, Jannis et al. (2023) ‘Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis’, European Journal of Neurology, 30(12), pp. 3809–3818. Available at: https://doi.org/10.1111/ene.16044.

Woelfle, Tim et al. (2023) ‘Smartwatch-derived sleep and heart rate measures complement step counts in explaining established metrics of MS severity’, Multiple Sclerosis and Related Disorders, 80. Available at: https://doi.org/10.1016/j.msard.2023.105104.